Clinical- and cost-ineffectiveness of targeted methicillin-resistant Staphylococcus aureus screening of high-risk patients admitted to a low-prevalence teaching hospital

Am J Infect Control. 2013 Nov;41(11):1137-8. doi: 10.1016/j.ajic.2013.03.297. Epub 2013 Jun 13.

Authors

Burke A Cunha¹, Paul Schoch, Eileen D Abruzzo

Affiliation

¹ Clinical Microbiology Laboratory, Infection Control Section, and Infectious Disease Division, Winthrop-University Hospital, Mineola, NY; School of Medicine, State University of New York, Stony Brook, NY. Electronic address: bacunha@winthrop.org.

PMID: 23768441
DOI: 10.1016/j.ajic.2013.03.297

No abstract available

Publication types

Letter

MeSH terms

Cost-Benefit Analysis
Diagnostic Tests, Routine / economics*
Diagnostic Tests, Routine / methods*
Hospitals, Teaching
Humans
Mass Screening / economics*
Mass Screening / methods*
Methicillin-Resistant Staphylococcus aureus / isolation & purification*
Staphylococcal Infections / diagnosis*
Staphylococcal Infections / economics*
Staphylococcal Infections / microbiology